Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease. - Wikidata - thesis-toulmin - TriplyDB

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.

http://www.wikidata.org/entity/Q37307467

about

New CSF biomarkers on the block.Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers.Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway.Electroconvulsive therapy does not alter the synaptic protein neurogranin in the cerebrospinal fluid of patients with major depression.Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study.Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.CSF neurogranin or tau distinguish typical and atypical Alzheimer disease.The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease.Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer's disease in late-middle-aged adults.Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease.Intrahippocampal injection of a lentiviral vector expressing neurogranin enhances cognitive function in 5XFAD mice.Genome-wide association study identifies two loci influencing plasma neurofilament light levels.Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease

P2860

Q41293029-77B1589C-D682-455A-83B3-8DDAEF6FC33D Q46490492-042E7499-995A-4768-AC33-D40550767F5B Q47200597-1B1AA967-D6E6-4745-AB18-F1978D3A1E7F Q47201004-2B436DEA-33ED-4B42-9FC1-61EFB73E41AD Q47590568-7DCB34DD-72FE-4DB9-987A-3601AD31C97E Q48185391-0248A017-AE0A-4066-A6B7-DB5498A441B4 Q48243501-FC164A1A-41BE-4087-AEDC-A1ADFD8AB7C0 Q50233550-4A37CF54-2F77-4DE6-8698-74430547E876 Q50532647-50D47BCB-4DA0-425E-BCDE-230098A1F1D3 Q50591921-EBCDAA0B-5DB0-491A-8A87-DA64D086550E Q52630015-211B14C7-4FE5-4F91-A437-86983C16CFCC Q52641743-A98874DF-8BC6-49B1-AC93-C3CC207448A9 Q55146363-D24469FC-45D7-4B22-9730-B6D23450599F Q57493750-1790A82A-2011-4836-ADC2-0F86EEE63070 Q58773968-20CA0F3D-429C-4D14-A338-24467EF0F39E

P2860

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.

http://www.wikidata.org/entity/Q37307467

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.

@en

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.

@nl

type

label

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.

@en

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.

@nl

prefLabel

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.

@en

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.

@nl

P1433

Q37307467-39443BA6-9891-44E8-B12F-E2FB4B6FE862

P1476

Q37307467-CC5E4FB5-B99A-4A40-9220-C2F33874FB2A

P2093

Q37307467-3F2DD1BB-93F1-4955-9F00-ECF3BD547F5A

Q37307467-50746A06-0318-44BA-AC0C-49D32B1B7B00

P2860

Q37307467-00462869-DAD3-4EDE-9C3A-E2CF8D70B5FA

Q37307467-01E1646D-F716-4D4C-8212-6F4514D80F3A

Q37307467-0C142E4D-A112-4C05-9DCD-BF5FDC15D922

Q37307467-0CF81BE1-4C38-4583-8654-E793871F75B5

Q37307467-0D95F480-4337-45C3-A1EB-31570AF40572

Q37307467-0DC34C51-A1C6-46B1-BC97-1AFC75CCE4EF

Q37307467-187DB7FE-2790-4239-9733-48B144C44A9A

Q37307467-1AF4CE59-807E-4F75-957B-E3317E911ED5

Q37307467-1EC64A44-FDB3-48B0-A1B6-A08B5B089679

Q37307467-202E39C7-24D5-4D33-9867-D98C3296E163

P304

Q37307467-02C4C722-05B8-4BF9-997A-7FA2DC93A5D2

P31

Q37307467-3FA64CDA-6A5B-41E7-A25D-9010DBA762BF

P356

Q37307467-B7B28285-097F-4ADB-AFF2-F0C1A9BA4EF4

P433

Q37307467-79FBEA45-014E-4011-A363-2A1EC83C4850

P478

Q37307467-163DC4FE-C8E3-4574-ABE6-C20204301725

P50

Q37307467-039D89B8-70BC-4277-9A35-685EE0F926F0

Q37307467-2705CA4B-A596-4492-A558-16F7024CE8CA

Q37307467-31F0D60E-E7D5-4069-87DC-CA26B1E0DA26

Q37307467-74EFB351-57E2-44E9-9C69-98456567698D

Q37307467-757B14BF-696C-4F33-B9AD-3730541F0905

Q37307467-83AD1787-4DC8-4562-A156-2487E0B8709C

Q37307467-FF56BBF0-71AF-4F55-B29C-EF1892945202

P577

Q37307467-F55E2B1F-3AF5-452B-99E8-4EDFB67B91C1

P698

Q37307467-C6016BFB-20B4-47D8-98E0-906713404B6E

P921

Q37307467-5FC9A946-FAC1-4CEF-828B-0396E70ECDD9

Q37307467-D8204167-96EB-43E7-B4E3-524116A03079

P932

Q37307467-68C02D29-A8DC-425E-B6C3-AACAC10A1F93

P356

P1433

EMBO Molecular Medicine

P1476

Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.

@en

P2093

Philip S Insel

http://www.w3.org/2001/XMLSchema#string

Sebastian Palmqvist

http://www.w3.org/2001/XMLSchema#string

P2860

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods.

Revolutionizing Alzheimer's disease and clinical trials through biomarkers

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Alzheimer's disease

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.

P304

1184-1196

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15252/EMMM.201606540

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Alzheimer's Disease Neuroimaging Initiative

Michael W. Weiner

Niklas Mattsson

Henrik Zetterberg

P577

2016-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27534871

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

cerebrospinal fluid

P932

5048367

http://www.w3.org/2001/XMLSchema#string